fluorescence imaging. Experimental variables (spontaneous rate, AP amplitude and duration, CT decay time course) are extracted and compared to the output of the model. Results. Insertion of Voltage Clock (upregulation of If and ICaL, and downregulation of IK1 and Ito) into the model showed the presence of automaticity with the characteristic slow late diastole depolarization. The maximum activation frequencies (0,7Hz) reached only the lower frequency range documented experimentally and found in the litterature (0,4 to 6Hz). Conclusion. Limitations in the rate of automaticity found emphasise the importance of exploring the Calcium Clock mechanism whose insertion may lead to higher spontaneous rates. In the future, a bifurcation analysis will give some insights on the dynamical mechanisms behind pacemaker generation in cultured NRVMs. Department of Neurophysiology, Cologne University, Cologne, Germany. Recent advances in the field of stem cell biology have made it possible to develop spontaneously beating myocytes, with cardiac electrophysiological and molecular phenotypes, from skin fibroblasts. Little is reported, however, on Ca-signaling properties of such cells. Here we quantify the Ca-signaling parameters of human iPSCs-derived cardiomyocytes developed from control and CPVT-afflicted subjects with F2483I point mutation in their RyRs. Single 3-6 days hiPSCs were patch-clamped using pipette solutions containing in mM: 0.1 fluo4, 0.1 Ca 2þ , 0.2 EGTA, 5 Na þ . I Ca and global Ca-transients were simultaneously measured. Ca-buffer concentrations were set such as to maintain the spontaneous beating frequencies of intact cells. I Ca averaged~8 pA/pF in 3 hiPSCs cell-lines (2 controls & one RyR-mutant), but with significant variation among cells (2-20 pA/ pF). I Ca-induced Ca-transients had rapid release but slow uptake kinetics, producing significant maintained components. The voltage-dependence of I Ca -activated Ca-transients was bell-shaped, reflecting the voltagedependence of I Ca in both control and mutant cells. The ratio of I Ca -activated to caffeine-triggered Ca-transients (efficiency of release) was~0.3. I NCX activated by caffeine Ca-transients ranged~2 pA/pF compared tõ 1.0pA/pF in adult cardiomyocytes. The gain of CICR was voltage dependent, similar to adult cardiomyocytes. Both adrenergic and Ca-channel agonists enhanced I Ca markedly, but failed to alter the gain of CICR significantly. Although there were no qualitative differences in Casignaling profiles of control and CPVT mutant myocytes, caffeinetriggered Ca-stores were smaller, CICR gain was larger at À30 but not at 0mV, and Ca-sparks longer in duration in mutant myocytes. We concluded that Ca-signaling parameters of hiPSCs-derived cardiomyocytes were similar to those of adult cardiomyocytes, but the CPVT-RyR mutant myocytes had somewhat altered Ca-signaling characteristics consistent with functionally defective RyRs. (Support by: NIH, RO1-HL16152, RO1-HL107600).
, 0.2 EGTA, 5 Na þ . I Ca and global Ca-transients were simultaneously measured. Ca-buffer concentrations were set such as to maintain the spontaneous beating frequencies of intact cells. I Ca averaged~8 pA/pF in 3 hiPSCs cell-lines (2 controls & one RyR-mutant), but with significant variation among cells (2-20 pA/ pF). I Ca-induced Ca-transients had rapid release but slow uptake kinetics, producing significant maintained components. The voltage-dependence of I Ca -activated Ca-transients was bell-shaped, reflecting the voltagedependence of I Ca in both control and mutant cells. The ratio of I Ca -activated to caffeine-triggered Ca-transients (efficiency of release) was~0.3. I NCX activated by caffeine Ca-transients ranged~2 pA/pF compared tõ 1.0pA/pF in adult cardiomyocytes. The gain of CICR was voltage dependent, similar to adult cardiomyocytes. Both adrenergic and Ca-channel agonists enhanced I Ca markedly, but failed to alter the gain of CICR significantly. Although there were no qualitative differences in Casignaling profiles of control and CPVT mutant myocytes, caffeinetriggered Ca-stores were smaller, CICR gain was larger at À30 but not at 0mV, and Ca-sparks longer in duration in mutant myocytes. We concluded that Ca-signaling parameters of hiPSCs-derived cardiomyocytes were similar to those of adult cardiomyocytes, but the CPVT-RyR mutant myocytes had somewhat altered Ca-signaling characteristics consistent with functionally defective RyRs. (Support by: NIH, RO1-HL16152, RO1-HL107600).
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Investigation of the Influence of hERG 1b on hERG Channel Pharmacology Aziza El Harchi, Dario Melgari, Jules C. Hancox. University of Bristol, Bristol, United Kingdom. hERG channels mediating the rapid delayed rectifier K þ current (I Kr ) are important for normal ventricular repolarization. In native cardiac tissues, hERG 1a subunit co-assembles with a subunit encoded by an alternate transcript, ''ERG1b'' which has a shorter N-terminus (1) and influences current kinetics (2). To date most pharmacological investigations of hERG sensitivity to drugs have been confined to hERG 1a. However, some studies suggest that hERG1b may confer altered pharmacological properties on hERG 1aþ1b (2,3). Here, we aim to explore and characterise the differential sensitivity of hERG currents (I hERG ) carried either by hERG1a, hERG1aþ1b or 1b alone to cardiac and non cardiac drugs, under conventional voltage clamp. Recordings were made at 37 C from Human embryonic kidney (hEK) 293B cells either stably expressing hERG 1a channel or transiently transfected with hERG1aþ hERG1b or hERG 1b alone. Whole-cell recordings utilised a standard external Tyrode's solution and K þ -based pipette solution. We found the anti-malarial agent chloroquine to inhibit hERG1a tail current at À40mV with an IC 50 of 0.89 5 0.06 mM (n=4-5 cells per concentration). Co-expression of hERG1a with hERG1b caused a shift in sensitivity with I hERG inhibited with an IC 50 of 1.5 5 0.06 mM (n= 5-7 cells per concentration). When I hERG was carried by hERG 1b alone, IC 50 for I hERG inhibition was 1.3 5 0.1 mM (n= 4-5 cells per concentration). Additional in vitro investigations of hERG cardiac and non cardiac drugs are ongoing to elucidate further the effect of the co-expression of hERG 1b subunit on I hERG drug sensitivity. This work was supported by the British Heart Foundation. From previous experimental and theoretical studies, it is well-known that gap junctional coupling, Na þ channel density, and Na þ channel localization influence the speed of electrical conduction velocity (CV) in multicellular cardiac tissue. However, two recent findings complicate our understanding of electrical conduction: (1) Na þ channels located at the intercalated disk region have different properties than those in the cell center; (2) in disease states, changes in gap junctional coupling occur in tandem with alterations in Na þ channel density, Na þ channel properties, and subcellular structure, which makes it difficult to determine the effects of each change. To gain a greater quantitative understanding of the factors that influence CV, we implemented a one-dimensional mathematical model of electrically coupled human ventricular myocytes. The model accounts for the possibility that electrical fields in the narrow clefts between adjacent cells can influence conduction. To determine how each model variable affects CV, we performed parameter sensitivity analysis under two conditions: (1) normal gap junctional conductance (400 kU resistance between cells), and (2) severely reduced gap junctional conductance (40 MU resistance between cells). Our simulation results predict the following: (1) Increasing the width of the cleft between adjacent cells increases CV under normal gap junctional conductance conditions but decreases CV when gap junctional coupling is low; (2) reducing cell coupling decreases CV under normal gap junctional conductance conditions, but further changes to coupling have little effect under low gap junctional conductance conditions, (3) Na þ channel activation kinetics and voltage dependence have a greater quantitative effect on CV with low than with normal gap junctional conductance. The simulations generate predictions that can be tested experimentally, and the results provide insight into changes in CV observed in disease.
1523-Pos Board B415 EAG Domains Regulate LQT Mutant hERG Channels in Induced Pluripotent Stem Cell-Derived Cardiomyocytes Qiangni Liu, Matthew Trudeau. University of Maryland, Baltimore, baltimore, MD, USA. The generation of human induced pluripotent stem (hiPS) cells provides a novel path for a wide range of disease research, including LQTS. The human ether-ago-go related gene (hERG) encodes the a-subunit of a voltage-gated potassium channel underlying IKr. hERG potassium channels contain nearly 300 different disease-causing mutations, which can lead to long QT syndrome (LQTS). Its N-terminal region contains an eag domain, which is important for modulating channel deactivation properties. R56Q is a point mutation located in the PAS domain that is associated with LQTS, a defect known to increase the rate of deactivation profoundly. Previous work showed that R56Q profoundly increased the rate of deactivation and lessend steady-state inactivation in Xenopus oocytes and mammalian HEK293 cells. We also showed that a soluble eag domain could restore the aberrant deactivation kinetics and inactivation properties of hERG R56Q. Here, we tested whether the delivery of adenoviral eag domains could rescue hERG R56Q channels expressed in cardiomyocytes derived from human iPSCs (hiPSC-CMs). We used whole-cell patch-clamp recordings to measure currents from iPSC-CMs expressing hERG, hERG R56Q and hERG R56Qþeag domains. We found that the adenoviral delivery of hERG R56Q to iPSC-CM resulted in channels with a faster rate of deactivation compared to that of WT hERG, indicating that hERG R56Q retained its aberrant gating in cardiomyocytes. We found that adenoviral delivery of eag domains restored slow deactivation kinetics to hERG R56Q channels in iPSC-CMs. The results indicated that adenoviral-delivery of a small polypeptide (i.e. eag domain) could restore the current deficiencies in a hERG LQT-mutant channel. This result indicates that eag domain polypeptides may be a biological therapeutic for LQTS. Monday, February 4, 2013 297a 
